Sinovac Biotech takes aim at health scourge HFMD with enterovirus vaccine
HONG KONG – Vaccine maker Sinovac Biotech Ltd.’s positive results from a phase III clinical trial for its enterovirus 71 (EV71) vaccine for hand, foot and mouth disease (HFMD) are welcome news in China since HFMD has emerged as a health scourge in China.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter